Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

KD PHARMA UK LIMITED

Company number 07614003

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 May 2024 CS01 Confirmation statement made on 26 April 2024 with no updates
30 Nov 2023 TM01 Termination of appointment of Markus Karl Altermatt as a director on 3 November 2023
03 Nov 2023 AA Full accounts made up to 31 December 2022
10 May 2023 CS01 Confirmation statement made on 26 April 2023 with no updates
10 May 2023 PSC08 Notification of a person with significant control statement
11 Apr 2023 AP01 Appointment of Miss Sanne Marie Lokke Olsen as a director on 1 April 2023
03 Apr 2023 TM01 Termination of appointment of Peter Stephen Trickett as a director on 1 April 2023
07 Sep 2022 AA Full accounts made up to 31 December 2021
10 May 2022 CS01 Confirmation statement made on 26 April 2022 with no updates
24 Sep 2021 AA Full accounts made up to 31 December 2020
11 May 2021 CS01 Confirmation statement made on 26 April 2021 with no updates
30 Dec 2020 MR01 Registration of charge 076140030004, created on 23 December 2020
29 Dec 2020 PSC07 Cessation of Epax Pharma Uk Holdings Unlimited as a person with significant control on 28 May 2019
14 Sep 2020 AA Full accounts made up to 31 December 2019
03 Sep 2020 MR04 Satisfaction of charge 076140030003 in full
19 May 2020 CS01 Confirmation statement made on 26 April 2020 with updates
23 Aug 2019 AD01 Registered office address changed from C/O Fladgate Llp 16 Great Queen Street London WC2B 5DG United Kingdom to Kd Pharma Uk Limited Seal Sands Middlesbrough TS2 1UB on 23 August 2019
13 Jun 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Declare dividend 21/05/2019
  • RES06 ‐ Resolution of reduction in issued share capital
13 Jun 2019 SH01 Statement of capital following an allotment of shares on 20 May 2019
  • GBP 3,255,830
13 Jun 2019 RESOLUTIONS Resolutions
  • RES14 ‐ Ca[italise £3255829 20/05/2019
  • RES13 ‐ 20/05/2019
13 Jun 2019 SH01 Statement of capital following an allotment of shares on 17 May 2019
  • GBP 3,255,830
13 Jun 2019 RESOLUTIONS Resolutions
  • RES14 ‐ Capitalise £3255829 17/05/2019
  • RES13 ‐ Allot and issue shares 17/05/2019
13 Jun 2019 SH01 Statement of capital following an allotment of shares on 16 May 2019
  • GBP 3,255,830
13 Jun 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Allot and issue shares 16/05/2019
  • RES14 ‐ Capitalise £3255829 16/05/2019
13 Jun 2019 SH01 Statement of capital following an allotment of shares on 15 May 2019
  • GBP 3,255,830